Mark J. Ratain to Drug Discovery
This is a "connection" page, showing publications Mark J. Ratain has written about Drug Discovery.
Connection Strength
0.322
-
A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension. Clin Pharmacol Ther. 2010 Mar; 87(3):303-10.
Score: 0.322